Penumbra (PEN) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026)
Penumbra (PEN) Property, Plant & Equipment (Net) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.89% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 7.35% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 8.56% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 14.29% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 10.46% |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 85.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.00% |
| Dec 31, 2025 | 87.47% |
| Sep 30, 2025 | 63.10% |
| Jun 30, 2025 | 46.99% |
| Mar 31, 2025 | -4.33% |
| Dec 31, 2024 | -13.83% |
| Sep 30, 2024 | -8.70% |
| Jun 30, 2024 | -12.51% |
| Mar 31, 2024 | 16.13% |
| Dec 31, 2023 | 11.81% |
| Sep 30, 2023 | 2.42% |
| Jun 30, 2023 | 3.94% |
| Mar 31, 2023 | 8.12% |
| Dec 31, 2022 | 10.46% |
| Sep 30, 2022 | 13.16% |
| Mar 31, 2022 | 19.90% |
| Dec 31, 2021 | 22.19% |
| Sep 30, 2021 | -12.75% |
| Mar 31, 2021 | -14.28% |
| Dec 31, 2020 | -7.03% |